大麻素和遗传模型:一篇重点关注CDKL5缺乏障碍的评论
Sean Massey1, Anita Quigley2,3,4,5, Simone Rochfort6,7
1Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC 3052, Australia.
International journal of molecular sciences
|October 16, 2024
概括
大麻素 (CBD) 和其他大麻素显示出治疗CDKL5缺乏症 (CDD),严重的儿科治疗的希望. 需要进一步的研究来探索它们在临床试验和临床前模型中的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 像CDKL5缺乏症 (CDD) 这样的儿科遗传会导致严重的,早期发作的发作,往往对常规治疗无反应.
- 有限的研究存在于CBD的大麻素疗法,目前的证据往往是事和缺乏组成数据.
- 放松的大麻立法激发了人们对植物性大麻素 (phytocannabinoids) 的兴趣,比如用于治疗的大麻 (CBD) 和 Δ9-四大麻 (THC).
研究的目的:
- 审查CBD,THC和其他大麻素对CDKL5缺乏障碍的治疗潜力.
- 探索大麻素在中断的CDD通路中的作用机制.
- 加强对大麻素作为治疗CDD的抗药物的进一步研究的论点.
主要方法:
- 审查现有的临床试验和临床前模型,研究大麻素在的疗效.
- 探索患者衍生的iPSC神经元和大脑器官,用于精确的大麻素剂量和药理学研究.
- 对事报告和手工大麻素产品的分析.
主要成果:
- CBD已显示出抗发作性质,特别是在LGS,DS和TSC等耐药遗传性中.
- 临床前模型和iPSC衍生的神经元允许对CDD中的大麻素效应进行受控调查.
- 关于CDD的具体数据有限,这突显了严格科学研究的必要性.
结论:
- 包括CBD和THC在内的大麻素代表了对CDD的潜在治疗途径.
- 利用先进的模型系统进行进一步的研究对于阐明机制和确认有效性至关重要.
- 加强基于大麻素的治疗方法的证据可以显著改善CDD患者和家人的生活质量.
相关概念视频
01:24Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K